Core Laboratories N.V. (CLB): Price and Financial Metrics
GET POWR RATINGS... FREE!
CLB POWR Grades
- CLB scores best on the Momentum dimension, with a Momentum rank ahead of 97.54% of US stocks.
- The strongest trend for CLB is in Stability, which has been heading up over the past 179 days.
- CLB ranks lowest in Sentiment; there it ranks in the 5th percentile.
CLB Stock Summary
- CLB's current price/earnings ratio is 74.88, which is higher than 90.61% of US stocks with positive earnings.
- The price/operating cash flow metric for Core Laboratories N V is higher than 86.64% of stocks in our set with a positive cash flow.
- Over the past twelve months, CLB has reported earnings growth of -157.87%, putting it ahead of merely 12.1% of US stocks in our set.
- Stocks that are quantitatively similar to CLB, based on their financial statements, market capitalization, and price volatility, are BLNK, LOTZ, CDMO, SAND, and INDO.
- Visit CLB's SEC page to see the company's official filings. To visit the company's web site, go to www.corelab.com.
CLB Valuation Summary
- In comparison to the median Energy stock, CLB's EV/EBIT ratio is 44.9% higher, now standing at 26.3.
- Over the past 243 months, CLB's price/sales ratio has gone up 1.5.
- Over the past 243 months, CLB's EV/EBIT ratio has gone up 13.
Below are key valuation metrics over time for CLB.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
CLB | 2021-09-03 | 2.9 | 8.6 | 39.6 | 26.3 |
CLB | 2021-09-02 | 2.9 | 8.7 | 39.9 | 26.4 |
CLB | 2021-09-01 | 2.9 | 8.5 | 38.9 | 25.9 |
CLB | 2021-08-31 | 2.9 | 8.5 | 39.1 | 26.0 |
CLB | 2021-08-30 | 2.9 | 8.7 | 39.9 | 26.4 |
CLB | 2021-08-27 | 3.0 | 8.9 | 41.0 | 27.1 |
CLB Growth Metrics
- The 4 year net cashflow from operations growth rate now stands at -53.46%.
- The 4 year price growth rate now stands at -88.42%.
- The 2 year revenue growth rate now stands at -3.07%.

The table below shows CLB's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2021-12-31 | 470.252 | 36.579 | 19.727 |
2021-09-30 | 458.862 | 17.579 | 30.576 |
2021-06-30 | 446.259 | 26.32 | 32.665 |
2021-03-31 | 443.25 | 43.83 | 18.889 |
2020-12-31 | 487.267 | 57.868 | -97.637 |
2020-09-30 | 530.296 | 91.016 | -100.844 |
CLB's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- CLB has a Quality Grade of B, ranking ahead of 82.88% of graded US stocks.
- CLB's asset turnover comes in at 0.785 -- ranking 22nd of 136 Petroleum and Natural Gas stocks.
- CKX, RES, and NESR are the stocks whose asset turnover ratios are most correlated with CLB.
The table below shows CLB's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-09-30 | 0.785 | 0.218 | 0.083 |
2021-06-30 | 0.762 | 0.223 | 0.090 |
2021-03-31 | 0.752 | 0.224 | 0.064 |
2020-12-31 | 0.805 | 0.231 | -0.109 |
2020-09-30 | 0.808 | 0.237 | -0.107 |
2020-06-30 | 0.847 | 0.248 | -0.076 |
CLB Price Target
For more insight on analysts targets of CLB, see our CLB price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $30.85 | Average Broker Recommendation | 1.95 (Hold) |
CLB Stock Price Chart Interactive Chart >
CLB Price/Volume Stats
Current price | $19.78 | 52-week high | $40.97 |
Prev. close | $20.55 | 52-week low | $18.41 |
Day low | $19.77 | Volume | 21,840 |
Day high | $20.43 | Avg. volume | 501,223 |
50-day MA | $25.12 | Dividend yield | 0.19% |
200-day MA | $26.93 | Market Cap | 915.97M |
Core Laboratories N.V. (CLB) Company Bio
Core Laboratories provides proprietary and patented reservoir description, production enhancement, and reservoir management services used to optimize petroleum reservoir performance. The company was founded in 1936 and is based in Amsterdam, the Netherlands.
Latest CLB News From Around the Web
Below are the latest news stories about Core Laboratories N V that investors may wish to consider to help them evaluate CLB as an investment opportunity.
Core Labs (CLB) Q4 Earnings Meet Estimates, Revenues SurpassCore Laboratories' (CLB) fourth-quarter earnings are on par with the consensus mark, while revenues beat estimates as a result of a strong performance in the Production Enhancement segment. |
Capital Asset Advisory Services LLC Buys iShares Russell 3000 ETF, iShares 7-10 Year Treasury ...Investment company Capital Asset Advisory Services LLC (Current Portfolio) buys iShares Russell 3000 ETF, iShares 7-10 Year Treasury Bond ETF, Vanguard Short-Term Inflation-Protected Securities, Vanguard Ultra-Short Bond ETF, iShares Short Treasury Bond ETF, sells Vanguard Total Bond Market ETF, iShares iBoxx USD High Yield Corporate Bond ETF, SPDR Dow Jones Industrial Average ETF, Utilities Select Sector SPDR ETF, SPDR MSCI USA StrategicFactors SM ETF during the 3-months ended 2021Q4, according |
Core Laboratories (CLB) Q4 2021 Earnings Call TranscriptImage source: The Motley Fool. Core Laboratories (NYSE: CLB)Q4 2021 Earnings CallFeb 03, 2022, 8:30 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood morning, and welcome to the Core Laboratories fourth quarter 2021 earnings conference call. |
Core Laboratories (CLB) Meets Q4 Earnings EstimatesCore Laboratories (CLB) delivered earnings and revenue surprises of 0% and 1.52%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock? |
CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2021 RESULTS FROM CONTINUING OPERATIONS:Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") reported fourth quarter 2021 revenue of $125,100,000. Core's operating income was $14,200,000, yielding operating margins of 11%, with earnings per diluted share ("EPS") of $0.06, all in accordance with U.S. generally accepted accounting principles ("GAAP"). EPS, ex-items, a non-GAAP financial measure, was $0.20. Income tax expense in the fourth quarter of 2021 was elevated primarily d |
CLB Price Returns
1-mo | -29.81% |
3-mo | -38.98% |
6-mo | -11.27% |
1-year | -49.14% |
3-year | -61.33% |
5-year | -78.85% |
YTD | -11.27% |
2021 | -15.73% |
2020 | -29.05% |
2019 | -34.35% |
2018 | -44.49% |
2017 | -6.83% |
CLB Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Continue Researching CLB
Want to see what other sources are saying about Core Laboratories N V's financials and stock price? Try the links below:Core Laboratories N V (CLB) Stock Price | Nasdaq
Core Laboratories N V (CLB) Stock Quote, History and News - Yahoo Finance
Core Laboratories N V (CLB) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...